| Literature DB >> 29179936 |
Emmanuelle Peters1, Thomas Ward2, Mike Jackson3, Peter Woodruff4, Craig Morgan5, Philip McGuire6, Philippa A Garety7.
Abstract
BACKGROUND: Cognitive models of psychosis propose that appraisals (ie, the interpretation and meaning attributed to experiences) are central to the transition from anomalous experiences to psychotic symptoms. In the Unusual Experiences Enquiry (UNIQUE) study, we investigated the role of appraisals by comparing individuals with persistent psychotic experiences without a need for care with patients and people without psychotic experiences.Entities:
Mesh:
Year: 2017 PMID: 29179936 PMCID: PMC5714590 DOI: 10.1016/S2215-0366(17)30409-1
Source DB: PubMed Journal: Lancet Psychiatry ISSN: 2215-0366 Impact factor: 27.083
Demographic and clinical characteristics of the three groups
| Site | ||||||
| London | 43 (52%) | 51 (55%) | 43 (51%) | .. | ||
| Bangor, Gwynedd | 40 (48%) | 41 (45%) | 41 (49%) | .. | ||
| Sources | 18 (22%) suggested by non-clinical participants, 65 (78%) from GP and university registers or circulars | 82 (89%) specialist groups and fora, 10 (11%) from SELCoH and GP registers | 29 (35%) from inpatient wards, 55 (65%) from community services | .. | ||
| Sex | χ2=31·3, df=2, p<0·001 | |||||
| Men | 26 (31%) | 25 (27%) | 55 (66%) | .. | ||
| Women | 57 (69%) | 67 (73%) | 29 (34%) | .. | ||
| Age (years) | 46 (13) | 46 (14) | 42 (13) | |||
| Ethnicity | χ2=20·1, df=2, p<0·001 (white | |||||
| White | 75 (90%) | 80 (87%) | 55 (66%) | .. | ||
| Mixed | 2 (2%) | 3 (3%) | 4 (5%) | .. | ||
| Asian | 2 (2%) | 2 (2%) | 2 (2%) | .. | ||
| Black | 3 (4%) | 6 (7%) | 22 (26%) | .. | ||
| Other | 1 (1%) | 1 (1%) | 1 (1%) | .. | ||
| Education (years) | 17·1 (4·0) | 16·8 (4·2) | 14·7 (5·8) | |||
| Spiritual | 34 (41%) | 82 (91%) | 62 (77%) | χ2=54·2; df=2 p<0·001 | ||
| Religion | χ2=68·2; df=4 p<0·001 | |||||
| None | 48 (58%) | 32 (35%) | 16 (19%) | .. | ||
| Mainstream | 28 (34%) | 19 (21%) | 55 (66%) | .. | ||
| Non-traditional | 7 (8%) | 41 (45%) | 13 (16%) | .. | ||
| IQ | 112 (16·5) | 105 (14·0) | 85 (14·2) | |||
| Psychotic experiences | ||||||
| Age at onset (years) | .. | 15 (12·3) | 22 (10·4) | |||
| Time since onset (years) | .. | 31·2 (15·3) | 20·2 (12·9) | |||
| Lifetime auditory hallucinations | .. | 71 (77%) | 74 (88%) | χ2=3·6, df=1, p=0·06 | ||
| AANEX score | ||||||
| Total lifetime | .. | 34·8 (4·9) | 36·3 (6·4) | |||
| Total current | .. | 28·6 (5·1) | 30·1 (6·2) | |||
| Meaning reference factor (current) | .. | 7·7 (2·1) | 7·5 (2·2) | |||
| First-rank symptoms factor (current) | .. | 7·5 (1·9) | 8·1 (2·5) | |||
| Hallucinatory-paranormal factor (current) | .. | 5·9 (1·7) | 5·1 (1·9) | |||
| Dissociative-perceptual factor (current) | .. | 3·8 (1·4) | 4·5 (1·8) | |||
| Cognitive-attentional factor (current) | .. | 3·8 (1·6) | 5·1 (1·7) | |||
| Diagnosis (ICD-10) | ||||||
| Schizophrenia | .. | .. | 53 (63%) | .. | ||
| Schizoaffective | .. | .. | 13 (16%) | .. | ||
| Psychosis NOS | .. | .. | 6 (7%) | .. | ||
| F30–39 | .. | .. | 11 (13%) | .. | ||
| Antipsychotic medications and doses | ||||||
| None | .. | .. | 8 (10%) | .. | ||
| Medicated | .. | .. | 76 (90%) | .. | ||
| Typical | .. | .. | 8 (10%) | .. | ||
| Atypical | .. | .. | 47 (62%) | .. | ||
| Clozapine | .. | .. | 21 (28%) | .. | ||
| >1 antipsychotic | .. | .. | 13 (17%) | .. | ||
| Additional psychotropic medications | .. | .. | 55 (72%) | .. | ||
| Median percentage maximum daily recommended dose (range) | .. | .. | 50% (12–100) | .. | ||
| Hospital admissions | .. | .. | 4·4 (3·6) | .. | ||
Data are number (%) or mean (SD). GP=general practitioner. SELCoH=South East London Community Health Study. AANEX=Appraisals of Anomalous Experiences Interview-Inventory.
One participant missing.
Answered ‘Yes’ to “Would you describe yourself as a spiritual person”.
Two participants missing.
Three participants missing.
Estimated with four subtests of the Wechsler Adult Intelligence Scale, third edition—Short Form (WAIS-III): information, block design, arithmetic, and digit symbol.
Six missing participants.
Potential range of scores for both totals 17–51.
p value Sidak adjusted for seven multiple tests.
Factor scores range from 3 to 9 (4–12 for meaning reference and first-rank symptoms).
Four participants missing.
Five participants missing.
Inter-rater reliability and comparison of clinical and non-clinical groups for AANEX-CAR appraisals
| κ (SE) | Percentage agreement (%) | Clinical (n=81) | Non-clinical (n=92) | Odds ratio (95% CI) | p value | |
|---|---|---|---|---|---|---|
| Biological | 0·89 (0·15) | 92·5% | 38·6% | 9·8% | 4·21 (1·72–10·27) | 0·016 |
| Drug-related | 0·77 (0·17) | 94·3% | 15·7% | 1·1% | 10·45 (1·26–86·50) | 0·216 |
| Spiritual | 0·68 (0·16) | 83·9% | 43·4% | 65·2% | 0·51 (0·26–1·02) | 0·380 |
| Other people | 0·72 (0·16) | 91·4% | 45·8% | 7·6% | 10·13 (3·79–27·09) | <0·008 |
| Psychological | 0·58 (0·14) | 83·9% | 34·9% | 21·7% | 1·28 (0·60–2·75) | 0·997 |
| No interpretation | NC | NC | 8·4% | 15·2% | 0·33 (0·10–1·08) | 0·426 |
| Supernatural | 0·76 (0·16) | 87·7% | 34·9% | 67·4% | 0·37 (0·18– 0·74) | 0·039 |
| Normalising | 0·96 (0·15) | 98·1% | 26·5% | 80·4% | 0·09 (0·04–0·21) | <0·008 |
| Valence | 0·79 (0·12) | 88·0% | 4 (3–5) | 1 (1–2) | 0·05 (0·05–0·11) | <0·005 |
| Threat | 0·88 (0·12) | 93·0% | 4 (2–5) | 1 (1–2) | 0·07 (0·04–0·15) | <0·005 |
| Externality | 0·77 (0·12) | 87·3% | 3 (2–5) | 3 (3–4) | 0·60 (0·32–1·12) | 0·442 |
| Abnormality | 0·88 (0·12) | 95·0% | 4 (2–5) | 1 (1–2) | 0·11 (0·05–0·22) | <0·005 |
| Controllability | 2 (1–3) | 4 (2–4) | 2·92 (1·57–5·43) | 0·005 | ||
| Agency | 0·38 (0·12) | 67·1% | .. | .. | .. | .. |
AANEX=Appraisals of Anomalous Experiences Intervew. AANEX-CAR=AANEX-Context, Appraisal, and Response. NC=not calculated because all scores except one were zeros.
Controlled for the three AANEX factors on which the groups differed and with site included as a covariate; percentages represent proportion present; scores for appraisal dimensions are medians (IQRs) and are scaled as follows: valence 1=strongly positive, 3=balance of positive and negative or neutral, 5=strongly negative; threat 1=completely harmless, 3=balanced or neutral, 5=definitely dangerous or harmful; externality 1=entirely due to internal factors, 3=balanced, 5=entirely external to self; abnormality 1=completely normal, 3=balanced, 5=completely abnormal; controllability 1=none, 3=some, 5=total; and agency 1=source entirely impersonal, 3=balanced, 5=entirely personal.
All Sidak-adjusted values: appraisal categories adjusted for eight multiple tests; appraisal dimensions adjusted for five multiple tests.
Non-weighted κ calculated because scores fell into two categories only.
Self-rated (ie, no inter-rater reliability calculated).
Dropped from analyses owing to poor inter-rater reliability.
Comparisons of threatening versus non-threatening appraisal scores, global ratings, personal relevance, and incorporation
| Cards task | 2·45 (2·54) | 0·40 (0·78) | 0·55 (0·78) | K=52·80, p<0·006 | |||
| Telepath application task | 2·05 (1·97) | 0·32 (0·65) | 0·54 (0·82) | K=58·58, p<0·006 | |||
| VASP task | 1·52 (1·86) | 0·20 (0·55) | 0·23 (0·53) | K=56·84, p<0·006 | |||
| Cards task | 5·06 (2·91) | 6·16 (2·76) | 6·25 (2·67) | K=8·64, p=0·076 | |||
| Telepath application task | 4·73 (3·17) | 5·56 (3·13) | 5·25 (3·06) | K=3·44, p=0·696 | |||
| VASP task | 5·91 (2·59) | 6·64 (2·42) | 6·55 (2·27) | K=2·20, p=0·910 | |||
| Cards task | 6·28 (3·09) | 3·61 (3·00) | 4·17 (2·90) | K=31·68, p<0·015 | |||
| Telepath application task | 6·16 (3·43) | 3·22 (3·15) | 4·20 (2·85) | K=31·72, p<0·015 | |||
| VASP task | 5·38 (3·25) | 3·46 (3·14) | 3·57 (2·81) | K=17·25, p<0·015 | |||
| Cards task | 1·70 (2·61) | 0·22 (0·80) | 0·13 (0·44) | K=42·23, p<0·015 | |||
| Telepath application task | 1·34 (2·25) | 0·26 (0·79) | 0·24 (0·96) | K=25·76, p<0·015 | |||
| VASP task | 3·08 (3·35) | 1·36 (2·46) | 1·24 (2·22) | K=19·96, p<0·015 | |||
| Cards task | 1·69 (2·79) | 0·16 (0·60) | 0·10 (0·37) | K=43·96, p<0·015 | |||
| Telepath application task | 1·22 (2·13) | 0·19 (0·81) | 0·13 (0·49) | K=31·31, p<0·015 | |||
| VASP task | 2·08 (3·03) | 0·95 (2·04) | 0·82 (1·78) | K=9·55 p=0·114 | |||
| Cards task | Yes 13 (16%) | Yes 3 (3%) | Yes 1 (1%) | χ2=15·30, p<0·015 | χ2=8·73, p=0·012, OR 5·84 (95% CI 1·60–21·34) | χ2=0·78, p=0·945, OR 2·70 (95% CI 0·28–26·45) | χ2=11·61, p=0·003 OR, 15·76 (95% CI 2·01–123·62) |
| Telepath application task | Yes 13 (16%) | Yes 4 (4%)) | Yes 1 (1%)) | χ2=13·65, p=0·015 | χ2=6·27, p=0·056, OR 4·05 (95% CI 1·26–12·98) | χ2=1·62, p=0·750, OR 3·81 (95% CI 0·42–34·84) | χ2=11·40, p=0·003, OR 15·45 (95% CI 1·97–121·09) |
| VASP task | Yes 21 (28%) | Yes 3 (3%) | Yes 2 (2%) | χ2=30·68, p<0·0015 | χ2=20·19, p<0·003, OR 11·33 (95% CI 3·23–39·76) | χ2=0·11, p=1·0, OR 1·37 (95% CI 0·22–8·38) | χ2=20·40, p<0·003, OR 15·46 (95% CI 3·48–68·63) |
| Cards task | Yes 30 (37%) | Yes 4 (4%) | .. | .. | χ2=29·65, p<0·0015, OR 13·2 (95% CI 4·40–39·64) | .. | .. |
| Telepath application task | Yes 32 (40%) | Yes 5 (6%) | .. | .. | χ2=29·12, p<0·0015, OR 11·20 (95% CI 4·09–30·66) | .. | .. |
| VASP task | Yes 26 (34%) | Yes 6 (6%) | .. | .. | χ2=20·27, p<0·0015, OR 7·31 (95% CI 2·82–18·95) | .. | .. |
Data for groups are mean (SD) or number (%). All p values are Sidak adjusted for six multiple tests for threatening and non-threatening appraisal ratings, 15 for global ratings, personal relevance, and incorporation, and three for individual group comparisons. K=Kruskal-Wallis. U=Mann-Whitney U. VASP=Virtual Acoustic Space Paradigm. OR=odds ratio.
Four participants had missing data for the cards task (five on personal relevance), two for the Telepath application task (three on incorporation), and five for the VASP task (six on threatening and non-threatening appraisals, seven on incorporation, eight on personal significance).
Two participants had missing data for the Telepath application task (three on global dimensions and incorporation).
One participant had missing data for the cards task (two on personal relevance), and one for the Telepath application task (one on non-threatening appraisals).
Effect sizes for Mann-Whitney U values calculated as r=Z / square root of N, where N is the number of samples; 0·1 indicates small effect, 0·3 medium, and 0·5 large.
FigureIndividual appraisals in the three anomalous experience tasks
Data are mean (SE). (A) Card task (control group n=82, non-clinical group n=92, and clinical group n=80). (B) Telepath application task (control group n=83, non-clinical group n=90, and clinical group n=82). (C) Virtual Acoustic Space Paradigm task (control group n=83, non-clinical group n=92, and clinical group n=78).